Anna Eshoo
FILE - In this Friday, May 8, 2020 file photo, a respiratory therapist pulls on a second mask over her N95 mask before adding a face shield as she gets ready to go into a patient's room in the COVID-19 Intensive Care Unit at a hospital in Seattle. Medical providers may soon return to using one medical N95 mask per patient, a practice that was suspended during the pandemic due to deadly supply shortages. (AP Photo/Elaine Thompson)
FDA: N95 masks, now plentiful, should no longer be reused

By Martha Mendoza And Juliet Linderman Apr. 23, 2021 10:31 AM EDT

A traveler waiting in line to cross a customs area into the U.S. at the McAllen-Hidalgo International Bridge looks back as a group of migrants are deported to Reynosa, Mexico, Thursday, March 18, 2021, in Hidalgo, Texas. A surge of migrants on the Southwest border has the Biden administration on the defensive. The head of Homeland Security acknowledged the severity of the problem Tuesday but insisted it's under control and said he won't revive a Trump-era practice of immediately expelling teens and children. (AP Photo/Julio Cortez)
Emergency sites for migrant children raising safety concerns

By Nomaan Merchant And Adriana Gomez Licon Mar. 18, 2021 03:57 PM EDT

Food and Drug Administration (FDA) Commissioner Stephen Hahn, testifies before a Senate Health, Education, Labor and Pensions Committee hearing on Capitol Hill in Washington, Tuesday, June 30, 2020. (Kevin Dietsch/Pool via AP)
Second Trump appointee out at FDA amid credibility concerns

By Matthew Perrone And Ryan J. Foley Sep. 02, 2020 12:06 PM EDT

In this image provided by Public Health Emergency, a department of Health and Human Services, Rick Bright is shown in his official photo from April 27, 2017, in Washington. Bright filed a complaint May 5, 2020, with the Office of Special Counsel, a government agency responsible for whistleblower complaints. He’s the former director of the Biomedical Advanced Research and Development Authority. Bright alleges he was removed from his job and reassigned to a lesser role because he resisted political pressure to allow widespread use of hydroxychloroquine, a malaria drug favored by President Donald Trump. (Health and Human Services via AP)
Senior scientist says administration ignored virus warnings

By Ricardo Alonso-Zaldivar, Michael Balsamo And Colleen Long May. 06, 2020 12:13 AM EDT

FILE - This Tuesday, April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. On Friday, April 24, 2020, the U.S. Food and Drug Administration warned doctors against prescribing the malaria drug to treat COVID-19 outside of hospitals or research settings. (AP Photo/David J. Phillip)
Whistleblower: US failed to prepare, sought quick virus fix

By Ricardo Alonso-Zaldivar, Michael Balsamo And Colleen Long May. 05, 2020 02:34 PM EDT